| # | Title | Journal | Year | Citations |
|---|
| 1 | Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II | Headache | 2001 | 1,933 |
| 2 | OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program | Headache | 2010 | 779 |
| 3 | Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study | Headache | 2008 | 683 |
| 4 | Migraine Diagnosis and Treatment: Results From the American Migraine Study II | Headache | 2001 | 631 |
| 5 | The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development | Headache | 2013 | 628 |
| 6 | Epidemiology of Chronic Daily Headache in the General Population | Headache | 1999 | 627 |
| 7 | Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness? | Headache | 2001 | 584 |
| 8 | Prevalence of Frequent Headache in a Population Sample | Headache | 1998 | 560 |
| 9 | Botulinum Toxin Type A as a Migraine Preventive Treatment | Headache | 2000 | 511 |
| 10 | Regulation of Calcitonin Gene-Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy | Headache | 2004 | 479 |
| 11 | Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial | Headache | 2007 | 446 |
| 12 | The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies | Headache | 2015 | 430 |
| 13 | Cervicogenic Headache: Diagnostic Criteria | Headache | 1998 | 427 |
| 14 | The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies | Headache | 2015 | 405 |
| 15 | Transformation of Episodic Migraine Into Daily Headache: Analysis of Factors | Headache | 1982 | 393 |
| 16 | Transformed or Evolutive Migraine | Headache | 1987 | 391 |
| 17 | The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice | Headache | 2019 | 390 |
| 18 | Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study | Headache | 2012 | 389 |
| 19 | Classification of Daily and Near-Daily Headaches: Proposed Revisions to the IHS Criteria | Headache | 1994 | 382 |
| 20 | Hypothalamic Activation in Spontaneous Migraine Attacks | Headache | 2007 | 353 |
| 21 | Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study | Headache | 2006 | 352 |
| 22 | Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain Management | Headache | 2003 | 347 |
| 23 | Migraine-associated Dizziness | Headache | 1992 | 346 |
| 24 | Medical Consultation for Migraine: Results From the American Migraine Study | Headache | 1998 | 340 |
| 25 | Impact of Migraine in the United States: Data from the National Health Interview Survey | Headache | 1993 | 337 |
| 26 | Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy? | Headache | 1999 | 337 |
| 27 | Headaches Associated With Personal Protective Equipment – A Cross‐Sectional Study Among Frontline Healthcare Workers During COVID‐19 | Headache | 2020 | 337 |
| 28 | Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study | Headache | 2013 | 330 |
| 29 | The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies | Headache | 2018 | 330 |
| 30 | Cervicogenic Headache: Diagnostic Criteria | Headache | 1990 | 328 |
| 31 | Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine | Headache | 2004 | 327 |
| 32 | The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies | Headache | 2013 | 319 |
| 33 | Efficacy of Gabapentin in Migraine Prophylaxis | Headache | 2001 | 317 |
| 34 | Migraine: Epidemiology, Impact, and Risk Factors for Progression | Headache | 2005 | 317 |
| 35 | Headache and Sleep: Examination of Sleep Patterns and Complaints in a Large Clinical Sample of Migraineurs | Headache | 2005 | 306 |
| 36 | Headache May Arise From Perturbation of Brain | Headache | 1987 | 305 |
| 37 | Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS‐II) | Headache | 2013 | 295 |
| 38 | Precipitating and Aggravating Factors of Migraine Versus Tension-type Headache | Headache | 2001 | 292 |
| 39 | Measuring the Functional Status and Well-Being of Patients with Migraine Headache | Headache | 1994 | 291 |
| 40 | Cluster Headache in the United States of America: Demographics, Clinical Characteristics, Triggers, Suicidality, and Personal Burden* | Headache | 2012 | 291 |
| 41 | Migraine and Major Depression: A Longitudinal Study | Headache | 1994 | 290 |
| 42 | The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice | Headache | 2021 | 286 |
| 43 | Voxel‐Based Morphometry Reveals Gray Matter Abnormalities in Migraine | Headache | 2008 | 283 |
| 44 | Information About Migraine Disability Influences Physicians' Perceptions of Illness Severity and Treatment Needs | Headache | 2001 | 282 |
| 45 | Modifiable Risk Factors for Migraine Progression | Headache | 2006 | 281 |
| 46 | Comorbidity of Migraine and Psychiatric Disorders—A National Population‐Based Study | Headache | 2008 | 281 |
| 47 | Response of Cluster Headache Attacks to Oxygen Inhalation | Headache | 1981 | 272 |
| 48 | Drug Induced Refractory Headache - Clinical Features and Management | Headache | 1990 | 272 |
| 49 | A Phase‐by‐Phase Review of Migraine Pathophysiology | Headache | 2018 | 272 |
| 50 | Changes in the Prevalence of Migraine and Other Headaches During the First Seven School Years | Headache | 1983 | 271 |
